Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Clinical trial NCT01362062 · COMPLETED
Trial details
- NCT number
- NCT01362062
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-26
- Primary completion
- 2015-01-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.